Dr. Stadtmauer is Chief of the Hematologic Malignancies Section within the Division of Hematology-Oncology, Department of Medicine of the Perelman School of Medicine, at the University of Pennsylvania in Philadelphia, PA. He is also the Co-Leader of the Abramson Cancer Center Hematologic Malignancies Research Program and the Penn Medicine Hematologic Malignancies Translational Center of Excellence. He has been associated with the University for over 30 years. He was the Co-Chairman of the Bone Marrow Transplant Committee of the NCI-funded Eastern Cooperative Oncology Group (ECOG) for ten years and is a member of the Myeloma and Leukemia Core Committees. He has been associated with the Center for International Bone Marrow Transplant Research (CIBMTR) for over a decade with leadership positions including chair of the nominating committee, co-chair Solid Tumor Working Committee and member of the Clinical Trials Advisory Committee. He is also a founding member of the Steering Committee of the NIH-sponsored Blood and Marrow Transplant Clinical Trial Network (BMT CTN) and elected to serve as Chairman in 2022. He is also a member of the International Myeloma Working Group (IMWG).